APA (7th ed.) Citation

JR, Y., EM, E., DM, M., NF, G., & G, B. (2026). Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations. Pharmaceutical research, 43(6), 1935. https://doi.org/10.1007/s11095-026-04095-3

Chicago Style (17th ed.) Citation

JR, Youssef, Elgammal EM, Mahdy DM, Ghazi NF, and Bebawy G. "Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations." Pharmaceutical Research 43, no. 6 (2026): 1935. https://doi.org/10.1007/s11095-026-04095-3.

MLA (9th ed.) Citation

JR, Youssef, et al. "Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations." Pharmaceutical Research, vol. 43, no. 6, 2026, p. 1935, https://doi.org/10.1007/s11095-026-04095-3.